The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA ...

The opioid industry in China is expected to rise at a CAGR of 3.3% through 2034. Based on application, the analgesia segment hold a 6.6% market share in 2024. The hospital pharmacies segment ...

Rather, he seemed to favor 12-step recovery programs, which have not been properly assessed for their impact on opioid users ... in fentanyl deaths is on the rise. Xylazine is a type of ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids’ addictive effects.

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Police and health officials have issued a warning against using highly-potent synthetic opioid drugs after seeing a rise in incidents across the country. Nationally, Nitazenes have been found in ...

The oral drug, branded Journavx, works by blocking pain signals at their source, unlike opioids — which trigger the brain's reward centers as they travel through the blood and then attach to ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they ...

It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive. That is because the drug, suzetrigine, made by Vertex Pharmaceuticals and to be ...

Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids’ addictive effects.